Practice Test GeeksBCACP - Board Certified Ambulatory Care Pharmacist Exam Practice Test
← All BCACP Flashcard Decks

Infectious Disease and Immunization Management Flashcards

6 cards from real BCACP practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 6 Infectious Disease and Immunization Management flashcards as text

  1. Which sexually transmitted infection (STI) is treated with a single dose of intramuscular ceftriaxone 500 mg as first-line per current CDC guidelines?

    Answer: Gonorrhea

    Current CDC STI guidelines recommend ceftriaxone 500 mg IM single dose as first-line treatment for uncomplicated gonorrhea.

  2. A pharmacist reviews a patient's chart and notes the patient has not received a Td booster in 12 years. What is the appropriate action?

    Answer: Administer Td booster now if no previous Tdap history, otherwise Tdap

    Td/Tdap is recommended every 10 years; if the patient has never received Tdap, it should be given as the booster to confer pertussis protection.

  3. Which antimicrobial is first-line for treatment of Clostridioides difficile (C. diff) infection of non-severe initial episodes per IDSA/SHEA guidelines?

    Answer: Oral vancomycin or fidaxomicin

    IDSA/SHEA guidelines recommend oral vancomycin or fidaxomicin over metronidazole for initial non-severe C. difficile infection due to superior cure rates.

  4. Pre-exposure prophylaxis (PrEP) with tenofovir/emtricitabine (Truvada) is indicated for which patient population?

    Answer: HIV-negative individuals at high risk for HIV acquisition

    PrEP is indicated for HIV-negative adults at substantial ongoing risk of HIV, such as those with high-risk sexual behavior or injection drug use.

  5. A patient asks about receiving the COVID-19 vaccine during a routine ambulatory visit. Which statement accurately reflects current vaccination guidance?

    Answer: Updated COVID-19 vaccines can be co-administered with other vaccines at the same visit

    CDC guidance states that COVID-19 vaccines may be co-administered with other vaccines without waiting periods.

  6. Which monitoring parameter is most critical when a patient is initiated on long-term trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis for Pneumocystis jirovecii pneumonia (PCP)?

    Answer: CBC with differential for myelosuppression and renal function

    Long-term TMP-SMX can cause myelosuppression and nephrotoxicity, requiring regular CBC and renal function monitoring.